• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究二月桂酸二丁基锡诱导脑损伤的潜在分子机制:网络毒理学和分子对接方法

Investigating the potential molecular mechanisms of dibutyltin dilaurate induced brain injury: a network toxicology and molecular docking approach.

作者信息

Hao Miao, Shi Naixu, Zhao Yuan, Chen Jiajun

机构信息

Scientific Research Center, China-Japan Union Hospital of Jilin University, 130033, Changchun, Jilin, China.

Department of Stomatology, China-Japan Union Hospital of Jilin University, 130033, Changchun, Jilin, China.

出版信息

Environ Pollut. 2025 Sep 15;381:126642. doi: 10.1016/j.envpol.2025.126642. Epub 2025 Jun 9.

DOI:10.1016/j.envpol.2025.126642
PMID:40499775
Abstract

Dibutyltin dilaurate (DBTDL) is an organotin compound widely used in industrial chemical generation, recognized for its toxicity upon exposure. However, its association with brain injury remains unexplored. This study aims to identify and validate the molecular targets of DBTDL-induced brain toxicity using network toxicology approach and molecular docking analysis, and to elucidate its mechanisms. We used comprehensive databases including ChEMBL, STITCH, GeneCards and OMIM to screen potential targets related to DBTDL exposure and brain injury. STRING database and Cytoscape software were further analyzed to identify the core targets. Functional and pathway enrichment analyses were conducted to infer biological relevance. Molecular docking was utilized to predict the interactions between DBTDL and its targets. Expression validation and mechanism exploration were performed in vitro using human microglial cell (HMC3) and human brain microvascular endothelial cells (HBMEC). We identified 143 potential target and 24 core targets related to DBTDL exposure and brain injury. The core targets were mainly enriched in signal transduction, synaptic, hormonal and inflammatory pathways. Molecular docking revealed high-affinity interactions between DBTDL and five core targets, demonstrating binding energies of -7.8 (AGT), -9.9 (AGTR1), -11.2 (GNB1), -6.7 (GNG2) and -3.7 (POMC). In vitro validation was conducted using HMC3 and HBMEC cells. These cells were exposed to concentrations ranging from 0.1 to 20 μM, which are reported to be biologically effective. The results revealed that DBTDL exhibits significant cytotoxicity on two types of cells. Additionally, DBTDL activates oxidative stress pathways by inducing intracellular ROS production. After DBTDL treatment, the expressions of all five core targets were significantly upregulated, and expressions of neurotrophic factors were also increased. Our results identified a set of core targets for DBTDL-induced brain injury and indicate that DBTDL may affect neuroinflammatory and neurotoxicity in the brain through these targets. Our results not only advance our knowledge of DBTDL-induced brain injury and potential therapeutic interventions, but also emphasize the need for regulatory measures to limit DBTDL exposure and protect public health.

摘要

二月桂酸二丁基锡(DBTDL)是一种广泛应用于工业化学品生产的有机锡化合物,因其暴露时具有毒性而闻名。然而,其与脑损伤的关联仍未得到探索。本研究旨在使用网络毒理学方法和分子对接分析来识别和验证DBTDL诱导脑毒性的分子靶点,并阐明其机制。我们使用了包括ChEMBL、STITCH、GeneCards和OMIM在内的综合数据库来筛选与DBTDL暴露和脑损伤相关的潜在靶点。进一步分析STRING数据库和Cytoscape软件以识别核心靶点。进行功能和通路富集分析以推断生物学相关性。利用分子对接预测DBTDL与其靶点之间的相互作用。使用人小胶质细胞(HMC3)和人脑微血管内皮细胞(HBMEC)在体外进行表达验证和机制探索。我们确定了143个与DBTDL暴露和脑损伤相关的潜在靶点和24个核心靶点。核心靶点主要富集于信号转导、突触、激素和炎症通路。分子对接揭示了DBTDL与五个核心靶点之间的高亲和力相互作用,显示出-7.8(AGT)、-9.9(AGTR1)、-11.2(GNB1)、-6.7(GNG2)和-3.7(POMC)的结合能。使用HMC3和HBMEC细胞进行体外验证。这些细胞暴露于0.1至20μM的浓度范围,据报道这些浓度具有生物学效应。结果显示DBTDL对两种类型的细胞均表现出显著的细胞毒性。此外,DBTDL通过诱导细胞内活性氧产生来激活氧化应激通路。DBTDL处理后,所有五个核心靶点的表达均显著上调,神经营养因子的表达也增加。我们的结果确定了一组DBTDL诱导脑损伤的核心靶点,并表明DBTDL可能通过这些靶点影响脑中的神经炎症和神经毒性。我们的结果不仅推进了我们对DBTDL诱导脑损伤及潜在治疗干预的认识,还强调了采取监管措施限制DBTDL暴露和保护公众健康的必要性。

相似文献

1
Investigating the potential molecular mechanisms of dibutyltin dilaurate induced brain injury: a network toxicology and molecular docking approach.研究二月桂酸二丁基锡诱导脑损伤的潜在分子机制:网络毒理学和分子对接方法
Environ Pollut. 2025 Sep 15;381:126642. doi: 10.1016/j.envpol.2025.126642. Epub 2025 Jun 9.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Solidago decurrens Lour. Controls LPS-Induced Acute Lung Injury by Reducing Inflammatory Responses and Modulating the TLR4/NF-κB/NLRP3 Signaling Pathway.一枝黄花通过减轻炎症反应和调节TLR4/NF-κB/NLRP3信号通路来控制脂多糖诱导的急性肺损伤。
J Ethnopharmacol. 2025 Jun 17:120172. doi: 10.1016/j.jep.2025.120172.
4
Mechanism of action of Pulsatilla chinensis (Bunge) Regel compounds in hepatocellular carcinoma (HCC) treatment: An integrated analysis combining network pharmacology, molecular docking, molecular dynamics simulations and luciferase reporter gene assay.白头翁化合物在肝细胞癌(HCC)治疗中的作用机制:结合网络药理学、分子对接、分子动力学模拟和荧光素酶报告基因检测的综合分析
J Ethnopharmacol. 2025 Jun 19;352:120176. doi: 10.1016/j.jep.2025.120176.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Understanding mechanisms of -derived exosome-like nanoparticles against breast cancer through an integrated metabolomics and network pharmacology analysis.通过综合代谢组学和网络药理学分析了解源自 - 的外泌体样纳米颗粒抗乳腺癌的机制。
Front Chem. 2025 Jun 6;13:1559758. doi: 10.3389/fchem.2025.1559758. eCollection 2025.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.